Growth Metrics

CVRx (CVRX) Other Non Operating Income (2020 - 2026)

CVRx's quarterly Other Non Operating Income came in at $593000.0 in Q1 2026, down 47.2% year-on-year from $1.1 million in Q1 2025, and down 10.15% quarter-over-quarter from $660000.0 in Q4 2025.

CVRx has reported Other Non Operating Income for 7 years, with the latest figure at $593000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income fell 47.2% year-over-year to $593000.0; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 20.17% YoY), and the FY2025 full-year result was $3.8 million, down 5.26% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $593000.0, down from $660000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.1 million in Q4 2022, with the low at -$57000.0 in Q1 2022.
  • Average Other Non Operating Income over 5 years is $797705.9, with a median of $944000.0 recorded in 2024.
  • Year-over-year, Other Non Operating Income sank 81.73% in 2022 and soared 1963.16% in 2023.
  • Tracing CVRX's Other Non Operating Income over 5 years: stood at $1.1 million in 2022, then decreased by 1.76% to $1.1 million in 2023, then retreated by 3.94% to $1.1 million in 2024, then sank by 38.43% to $660000.0 in 2025, then decreased by 10.15% to $593000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $593000.0 (Q1 2026), $660000.0 (Q4 2025), and $875000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 CVRx 144.43 Mn 72.13 Mn 12.88 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 593,000.00
Dec 31, 2025 660,000.00
Sep 30, 2025 875,000.00
Jun 30, 2025 1.11 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 917,000.00
Jun 30, 2024 944,000.00
Mar 31, 2024 1.04 Mn
Dec 31, 2023 1.12 Mn
Sep 30, 2023 1.06 Mn
Jun 30, 2023 616,000.00
Mar 31, 2023 1.06 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 328,000.00
Jun 30, 2022 -34,000.00
Mar 31, 2022 -57,000.00
Dec 31, 2021 -1.36 Mn
Sep 30, 2021 1.80 Mn
Jun 30, 2021 -11.44 Mn
Mar 31, 2021 -3.79 Mn
Dec 31, 2020 -632,000.00
Sep 30, 2020 455,000.00
Jun 30, 2020 33,000.00